Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-16 · accession 0001607737-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-21 | 2026-01-16 | JAZZ | GALA RENEE D | Pres, CEO | F - Tax | $171.16 | -5,371 | 115.2K | -4% | -$919.3K | |
| 2026-01-21 | 2026-01-16 | JAZZ | GALA RENEE D | Pres, CEO | A - Grant | $0.00 | +12.7K | 120.6K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-01-16 | F | D | 5,371 | $171.16 | 115,230 | D | — | — | |
| 2 | Common | Ordinary Shares | 2026-01-16 | A | A | 12,741 | $0.00 | 120,601 | D | — | — |